As a member of the Healthcare, Life Sciences & Pharmaceuticals industry team, Rachael focuses her practice on intellectual property litigation.
Before joining the firm, Rachael spent more than 15 years performing scientific/medical research. She was a research scientist at NASA (Johnson Space Center), where she performed research on the biological risks of space exploration missions, such as cancer, radiation sickness and cardiovascular disease. She performed cell-based and animal studies, including the creation of a three-dimensional transgenic co-culture cardiac cell model used to minimize the toxic effects of reduced gravity. She also tested novel countermeasures (nanoparticles, vaccines, nutraceuticals) against the biological effects of acute radiation exposure. Rachael lectured at NASA’s Lunar Planetary Institute and also volunteered as a food analyst (taste tester) in NASA’s Space Food Systems Laboratory.
Rachael earned her Ph.D. in biochemistry at Rush University Medical Center’s department of biochemistry. She has an extensive background in biotechnology, biochemistry and cell biology due to her research of human diseases. During more than a decade of medical research in the laboratory, she has elucidated mechanisms of cancer metastasis, identified ovarian carcinoma biomarkers, performed genomic and proteomic analyses of primary and secondary tumors, researched cell signaling and protein-protein interactions in heterologous cell-based cancer models, and developed novel cell-based assays to assess novel treatments of tumor cells. In addition, Rachael has published several peer-reviewed articles and book chapters on the topic of medical research.